La catena delle opzioni mostra i dati chiave delle opzioni azionarie di XWELL a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per XWELL..

XWELL (NASDAQ:XWEL) Azioni, Catena delle Opzioni

XWELL

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

XWELL Inc

As of Nov. 8, 2024, three stocks in the financials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Upstart Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>)</h3>
<ul>
<li>On Nov. 7, Upstart reported quarterly losses of seven cents per share which beat the analyst consensus estimate for losses of 15 cents. Quarterly revenue came in at $162.14 million which beat the analyst consensus estimate of $150.22 million and is an increase over sales of $134.55 million from the same period last year. "With 43% sequential growth in lending volume and a return to positive adjusted EBITDA, we continue to strengthen Upstart's position as the fintech leader in artificial intelligence," said Dave Girouard, CEO of Upstart. "Even without a significant boost from the macroeconomy, we're back in growth mode." The company's stock gained around 29% over the past month and has a <a href="https://www.benzinga.com/quote/UPST">52-week high of $57.31</a>.</li>
<li>RSI Value: 79.08&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>UPST Price Action: Shares of Upstart gained 2.8% to close at $55.47 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Toast Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>)</h3>
<ul>
<li>On Nov. 7, Toast reported better-than-expected third-quarter financial results. &#8220;Toast delivered a strong third quarter, adding approximately 7,000 net new locations, growing our recurring gross profit streams1 35%, and achieving Adjusted EBITDA of $113 million. We are well positioned to finish out the year strong and carry this momentum into 2025,&#8221; said Toast CEO and Co-Founder Aman Narang. The company's stock gained around 13% over the past month and <a href="https://www.benzinga.com/quote/TOST">has a 52-week high</a> of $33.00.</li>
<li>RSI Value: 85.15</li>
<li>TOST Price Action: Shares of Toast gained 1.7% to close at $32.67 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Flywire Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>)</h3>
<ul>
<li>On Nov. 7, Flywire reported better-than-expected third-quarter financial results and issued FY24 revenue guidance above estimates. &#8220;Our third quarter results highlight our ability to capture higher payment volumes with new and existing clients, signaling the growth potential within our accounts and verticals.&#8221; said Mike Massaro, CEO of Flywire The company's stock gained around 11% over the past month and has a <a href="https://www.benzinga.com/quote/FLYW">52-week high</a> of $31.54.</li>
<li>RSI Value: 77.08</li>
<li>FLYW Price Action: Shares of Flywire gained 2% to close at $18.30 on Thursday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/41820056/how-to-earn-500-a-month-from-nvidia-stock-after-trump-win">How To Earn $500 A Month From Nvidia Stock After Trump Win</a></li>
</ul>

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

FLYW

TOST

UPST

Top 3 Financials Stocks That May Fall Off A Cliff This Month

WIIM

AKAM

Akamai Technologies shares are trading lower after the company issued FY24 guidance below estimates.

PINS

Pinterest shares are trading lower after the company reported worse-than-expected Q3 EPS results.

Ocugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) reported quarterly sales of $1.136 million which beat the analyst consensus estimate of $300.000 thousand by 278.67 percent. This is a 69.29 percent decrease over sales of $3.699 million the same period last year.

Earnings

Earnings Beats

OCGN

Ocugen Q3 Sales $1.136M Beat $300.000K Estimate

AXON

Axon Enterprise shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 revenue guidance above estimates.

Toast shares are trading higher after the company reported better-than-expected Q3 financial results.

RBC Capital analyst Mike Dahl downgrades Installed Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBP#NYSE">IBP</a>) from Sector Perform to Underperform and lowers the price target from $203 to $197.

Downgrades

Price Target

Analyst Ratings

RBC Capital Downgrades Installed Building Prods to Underperform, Lowers Price Target to $197

TELUS Q3 2024 Adj. EPS C$0.28 Beats C$0.23 Estimate, Sales C$5.099B Beat C$5.050B Estimate

TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.01 by 400 percent. This is a 73.68 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $658.00 million which beat the analyst consensus estimate of $647.14 million by 1.68 percent. This is a 0.75 percent decrease over sales of $663.00 million the same period last year.

TIXT

TELUS Intl Q3 2024 Adj EPS $0.05 Beats $0.01 Estimate, Sales $658.00M Beat $647.14M Estimate

Marcus & Millichap Earlier Reported Q3 EPS $(0.14) Beats $(0.19) Estimate, Sales $168.51M Beat $160.90M Estimate

Raymond James analyst Robert Dodd downgrades WhiteHorse Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHF#NASDAQ">WHF</a>) from Outperform to Market Perform.

Raymond James Downgrades WhiteHorse Finance to Market Perform

Earnings Misses

Brookfield Bus Partners Q3 2024 EPS $1.39, Revenues $9.232B

RBC Capital analyst Leonid Timashev initiates coverage on Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Outperform rating and announces Price Target of $80.

Initiation

CYTK

RBC Capital Initiates Coverage On Cytokinetics with Outperform Rating, Announces Price Target of $80

Adjusted EBITDA is expected to be in the range of $880 million to $920 million. Capital expenditures are expected to be approximately $250 million.

Guidance

Advanced Drainage Systems Cuts FY25 Net Sales Outlook From $2.925B - $3.025B To $2.900B - $2.975B,  Est $2.985B

Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) said on Thursday after market close that it is on track to turn a gross profit in the fourth quarter despite a<a href="https://www.benzinga.com/news/24/10/41223011/rivians-production-guidance-cut-spurred-by-miscommunication-with-atlanta-based-supplier-resulting-in"> production disruption flagged earlier this year.</a>
What Happened: The EV maker on Thursday also reaffirmed its 2024 delivery outlook of 50,5000 to 52,000 vehicles for the full year, helping relieve investor worries.
Rivian cut its annual production forecast last month by as much as 18% to between 47,000 and 49,000 electric vehicles, citing production disruption owing to a component shortage. However, the production disruption will not seemingly impact the company&#8217;s delivery targets for the year. 
For the third quarter, the EV startup <a href="https://www.benzinga.com/news/earnings/24/11/41825787/rivian-q3-earnings-highlights-revenue-eps-miss-ceo-confident-in-q4-gross-profit-r2-being-fundamenta">reported revenue of $874 million</a>, which missed a Street consensus estimate of $1.00 billion, and a loss of 99 cents per share, missing a Street consensus loss of 92 cents per share. 
The company also announced a five-year strategic supply agreement for batteries with&nbsp;LG Energy Solutions for its R2 SUV, slated for launch in the first half of 2026. 
Why It Matters: Rivian produced 13,157 vehicles in the third quarter and delivered 10,018 vehicles. Currently, the company has only two vehicles in production- the R1T truck and the R1S SUV with a starting price of around $70,000. 
The company is looking to expand its total addressable market with the R2 SUV expected to be priced around $45,000, in the same price range as Tesla Inc&#8217;s best-selling Model Y SUV. 
The company is also planning to start deliveries of its<a href="https://www.benzinga.com/news/24/03/37552684/rivian-almost-catches-up-to-teslas-ev-lineup-with-new-r2-r3-but-theres-no-cybertruck-fighter-yet"> R3 crossover after the R2.</a> The crossover is expected to be priced lower than the R2 SUV but it is unclear whether the R3's price will undercut the Tesla Model 3 or remain within the same range.
Price Action: Rivian shares closed up 3.35% at $10.04 on Thursday. The stock is down 52.4% year-to-date, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41803756/xpeng-flying-car-can-be-mastered-in-3-hours-says-company-chairman" target="_blank" rel="noreferrer noopener">XPeng Flying Car Can Be Mastered In 3 Hours, Says Company Chairman</a></li>
</ul>
Image via Shutterstock

Tech

General

RIVN

Rivian Says It Is On Track For 2024 Delivery Targets Despite Production Challenges

Hippo Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.95) by 64.21 percent. The company reported quarterly sales of $95.500 million which beat the analyst consensus estimate of $94.064 million by 1.53 percent. This is a 65.51 percent increase over sales of $57.700 million the same period last year.

HIPO

Hippo Holdings Q3 2024 GAAP EPS $(0.34) Beats $(0.95) Estimate, Sales $95.500M Beat $94.064M Estimate

Macquarie analyst Paul Golding downgrades Planet Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) from Outperform to Neutral and raises the price target from $91 to $99.

PLNT

Macquarie Downgrades Planet Fitness to Neutral, Raises Price Target to $99

Fiscal 2025 Outlook
The Company's outlook for 2025 was updated as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(as of November 8, 2024)</td>
<td colspan="1" rowspan="1">Updated Fiscal 2025 Guidance</td>
<td colspan="1" rowspan="1">Previous Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Sales</td>
<td colspan="1" rowspan="1">$200 million to $210 million</td>
<td colspan="1" rowspan="1">$200 million to $210 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gross Margin</td>
<td colspan="1" rowspan="1">23% to 24% of sales</td>
<td colspan="1" rowspan="1">22% to 23% of sales</td>
</tr>
<tr>
<td colspan="1" rowspan="1">SG&amp;A expense (including amortization)(1)</td>
<td colspan="1" rowspan="1">17.0% to 18.0% of sales</td>
<td colspan="1" rowspan="1">16.5% to 17.5% of sales</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA(2)</td>
<td colspan="1" rowspan="1">$18.0 million to $21.0 million</td>
<td colspan="1" rowspan="1">$16.5 million to $19.5 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Effective Tax Rate</td>
<td colspan="1" rowspan="1">20% to 22%</td>
<td colspan="1" rowspan="1">20% to 22%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">$13.0 million to $18.0 million</td>
<td colspan="1" rowspan="1">$10.0 million to $15.0 million</td>
</tr>
</tbody>
</table>
</figure><figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(1)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Includes approximately $6.5 million to $7.5 million of BN supplemental performance bonus, equity-based compensation, and ERP conversion costs included in SG&amp;A expense.</td>
</tr>
</tbody>
</table>
</figure>

Graham Reaffirms 2025 Net Sales Outlook Of $200M-$210M Vs. $205.40M Est.; Raises Gross Margin Guidance To 23%-24% From 22%-23% And Adj. EBITDA To $18M-$21M From $16.5M-$19.5M

Embraer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERJ#NYSE">ERJ</a>) reported quarterly earnings of $1.20 per share which beat the analyst consensus estimate of $0.60 by 100 percent. The company reported quarterly sales of $1.69 billion which beat the analyst consensus estimate of $1.59 billion by 6.34 percent. This is a 31.73 percent increase over sales of $1.28 billion the same period last year.

Embraer-Empresa Brasileira De Aeronautica

Embraer Q3 2024 Adj EPS $1.20 Beats $0.60 Estimate

Keybanc analyst Scott Schoenhaus upgrades Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) from Sector Weight to Overweight and announces $70 price target.

Upgrades

DOCS

Keybanc Upgrades Doximity to Overweight, Announces $70 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
XWELL (NASDAQ:<a href="https://investorplace.com/stock-quotes/xwel-stock-quote/">XWEL</a>) just reported results for the fourth quarter of 2023.<ul><li>XWELL reported earnings per share of -$1.57. This was below the analyst estimate for EPS of -82 cents.</li><li>The company reported revenue of $7.40 million.</li><li>This was 15.59% worse than the analyst estimate for revenue of $8.77 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/xwel-stock-earnings-xwell-for-q4-of-2023/">XWEL Stock Earnings: XWELL Misses EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

XWEL Stock Earnings: XWELL Misses EPS, Misses Revenue for Q4 2023

XWELL reports Q1 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
XWELL (NASDAQ:<a href="https://investorplace.com/stock-quotes/xwel-stock-quote/">XWEL</a>) just reported results for the first quarter of 2024.<ul><li>XWELL reported earnings per share of -60 cents.</li><li>The company reported revenue of $8.73 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/xwel-stock-earnings-xwell-for-q1-of-2024/">XWEL Stock Earnings: XWELL Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

XWEL Stock Earnings: XWELL Reported Results for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!



Moving stocks this morning are an acquisition deal, a clinical trial launch, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chuy&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/chuy-stock-quote/">CHUY</a>) stock is rocketing more than 46% on a <a href="https://www.nasdaq.com/press-release/darden-restaurants-acquire-chuys-holdings-inc-approximately-605-million-transaction">$605 million acquisition deal</a>.</li>



<li>Onconetix (NASDAQ:<a href="https://investorplace.com/stock-quotes/onco-stock-quote/">ONCO</a>) shares are soaring over 43% alongside heavy pre-market trading.</li>



<li>Apollomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/aplm-stock-quote/">APLM</a>) stock is surging more than 25% with strong early morning trading.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) shares are rising over 23% as it <a href="https://www.nasdaq.com/press-release/bionomics-initiates-affirm-1-phase-3-clinical-trial-bnc210-social-anxiety-disorder">kicks off a Phase 3 clinical trial</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) stock is increasing more than 18% with strong pre-market trading.</li>



<li>ZimVie (NASDAQ:<a href="https://investorplace.com/stock-quotes/zimv-stock-quote/">ZIMV</a>) shares are heading over 13% higher without any clear news on Thursday morning.</li>



<li>SAI.TECH Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/sai-stock-quote/">SAI</a>) stock is gaining more than 12% on a <a href="https://www.globenewswire.com/news-release/2024/07/18/2914992/0/en/SAI-TECH-Global-Corporation-Announces-Share-Repurchase-Program.html">share repurchase program</a>.</li>



<li>MultiMetaVerse (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) shares are climbing over 11% as it continues a recent rally.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) stock is jumping more than 10% despite a lack of news today.</li>



<li>XWELL (NASDAQ:<a href="https://investorplace.com/stock-quotes/xwel-stock-quote/">XWEL</a>) shares are up over 10% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Leslies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lesl-stock-quote/">LESL</a>) stock is diving more than 21% on <a href="https://www.nasdaq.com/press-release/leslies-inc-announces-preliminary-third-quarter-fiscal-2024-financial-results-and">preliminary earnings and guidance</a>.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) shares are rumbling over 13% after a massive rally yesterday.</li>



<li>Domino&rsquo;s Pizza (NYSE:<a href="https://investorplace.com/stock-quotes/dpz-stock-quote/">DPZ</a>) stock is sliding more than 13% with the release of its <a href="https://ir.dominos.com/static-files/68ecdbfc-bd1c-486a-a574-d6f54b7e5132">Q2 earnings report</a>.</li>



<li>CBL International (NASDAQ:<a href="https://investorplace.com/stock-quotes/banl-stock-quote/">BANL</a>) shares are taking an over 12% beating on Thursday morning as it retreats from a rally yesterday.</li>



<li>WiMi Hologram Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>) stock is dropping close to 12% after an unexpected rally yesterday.</li>



<li>Beyond Meat (NASDAQ:<a href="https://investorplace.com/stock-quotes/bynd-stock-quote/">BYND</a>) shares are falling more than 11% on <a href="https://www.wsj.com/articles/beyond-meat-engages-bondholders-for-restructuring-talks-7de6b8ae">restructuring talks with bondholders</a>.</li>



<li>American Rebel (NASDAQ:<a href="https://investorplace.com/stock-quotes/areb-stock-quote/">AREB</a>) stock is decreasing over 11% this morning after rallying on Wednesday.</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are slipping more than 10% <a href="https://investorplace.com/2024/07/why-is-aditxt-adtx-stock-up-72-today/">following a rally yesterday</a>.</li>



<li>Stardust Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdst-stock-quote/">SDST</a>) stock is dipping over 10% <a href="https://investorplace.com/2024/07/stardust-power-sdst-stock-pops-140-days-after-debut-what-to-know/">after a surprise rally yesterday</a>.</li>



<li>GRI Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/">GRI</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

XWELL announces $1.4M registered direct offering

XWELL (XWEL) has provided an announcement. XWELL, Inc. has recently struck a deal with institutional and accredited investors to sell over 650,000 ...

XWELL Capital Boost: New Share Deals and Investor Agreements

XWELL reports Q2 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
XWELL (NASDAQ:<a href="https://investorplace.com/stock-quotes/xwel-stock-quote/">XWEL</a>) just reported results for the second quarter of 2024.<ul><li>XWELL reported earnings per share of -48 cents.</li><li>The company reported revenue of $9.28 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/xwel-stock-earnings-xwell-for-q2-of-2024/">XWEL Stock Earnings: XWELL Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

XWEL Stock Earnings: XWELL Reported Results for Q2 2024

An announcement from XWELL ( ($XWEL) ) is now available. XWELL Inc. has appointed Ezra Ernst as its new President and CEO, aiming to spur growth an...

XWELL Names Ezra Ernst as President for Strategic Growth

XWELL names Ezra Ernst as CEO

ADTX

APLM

APVO

AREB

BANL

BNOX

BYND

CHUY

LESL

ONCO

SDST

WIMI

XWEL

ZIMV

Press Releases

XWELL Opens New XpresSpa Location at Philadelphia International Airport

XWELL Announces Director Candidate Nomination Notice Submitted by CPC is Invalid

CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors

Comments

XWELL

XWELL (XWEL) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO